Microbot Medical (MBOT) Depreciation & Amortization (CF) (2010 - 2026)

Microbot Medical has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $12000.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 20.0% year-over-year to $12000.0; the trailing twelve-month figure through Mar 2026 stood at $44000.0 (down 43.59% YoY), and the FY2025 full-year result was $47000.0, down 48.35% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $12000.0, up from $10000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $35000.0 in Q4 2023, with the low at $10000.0 in Q3 2025.
• Historically, Depreciation & Amortization (CF) has averaged $21058.8 across 5 years, with a median of $23000.0 in 2022.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 64.29% — and 2025, when it sank 61.54%.
• Microbot Medical's Depreciation & Amortization (CF) stood at $33000.0 in 2022, then climbed by 6.06% to $35000.0 in 2023, then retreated by 25.71% to $26000.0 in 2024, then slumped by 61.54% to $10000.0 in 2025, then rose by 20.0% to $12000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $12000.0 (Q1 2026), $10000.0 (Q4 2025), and $10000.0 (Q3 2025), per Business Quant data.